Average Co-Inventor Count = 5.66
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Genentech, Inc. (285 from 3,206 patents)
2. Gilead Biologics, Inc. (13 from 16 patents)
3. Genetech, Inc. (11 from 98 patents)
4. Gilead Sciences, Inc. (1 from 910 patents)
5. Ashibio, Inc. (1 from 1 patent)
311 patents:
1. 12421321 - Methods for treating fibrodysplasia ossificans progressiva
2. 11634505 - Antibodies to matrix metalloproteinase 9
3. 10800857 - Antibodies to matrix metalloproteinase 9
4. 10494443 - LOX and LOXL2 inhibitors and uses thereof
5. 9732156 - Methods of treating rheumatoid arthritis using antibodies to matrix metalloproteinase 9
6. 9550836 - Method of detecting human matrix metalloproteinase 9 using antibodies
7. 9289447 - Chemotherapeutic methods and compositions
8. 9176139 - LOX and LOXL2 inhibitors and uses thereof
9. 9107935 - Chemotherapeutic methods and compositions
10. 9085630 - Compositions and methods for the treatment of tumor of hematopoietic origin
11. 8927700 - Catalytic domains from lysyl oxidase and LOXL2
12. 8728480 - Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof
13. 8691222 - NLRR-1 antagonists and uses thereof
14. 8680246 - Antibodies that bind to lysyl oxidase-like 2 (LOXL2)
15. 8679485 - Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis